Catalyst Wire Dossier Catalyst Wire Dossier

MRKAd5 HIV-1 Gag/Pol/Nef

MRKAd5 HIV-1 Gag/Pol/Nef · Merck
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRKAd5 HIV-1 Gag/Pol/Nef, covering 2021-10-15 to 2021-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults [Phase 2]

See pricing